Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01789346 · ClinicalTrials.gov registry record · NA
Pilot Study of a Novel 532nm KTP Laser for the Treatment of Fresh Surgical Scars
A NA study, sponsored by Cutera.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01789346 is a NA study that has completed, run by Cutera. The registered enrollment target is 20 participants.
The verdict
NCT01789346, a NA study, has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of the 532nm potassium titanyl phosphate (KTP) laser in comparison with the 595nm pulsed-dye laser (PDL) for the treatment of fresh surgical scars.
Interventions
- DEVICE 532nm KTP
- DEVICE 595nm PDL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01789346
The ClinicalTrials.gov registry entry for NCT01789346 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cutera, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 532nm KTP is the first listed.
NCT01789346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01789346 about?
NCT01789346 is a clinical study titled "Pilot Study of a Novel 532nm KTP Laser for the Treatment of Fresh Surgical Scars". The purpose of this study is to evaluate the safety and efficacy of the 532nm potassium titanyl phosphate (KTP) laser in comparison with the 595nm pulsed-dye laser (PDL) for the treatment of fresh surgical scars.
What is the current status of trial NCT01789346?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-02. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01789346?
The interventions under investigation include: 532nm KTP (DEVICE), 595nm PDL (DEVICE).
Who is sponsoring clinical trial NCT01789346?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.